Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 3
2006 3
2008 5
2009 3
2010 9
2011 3
2012 3
2013 7
2014 1
2015 8
2016 8
2017 5
2018 8
2019 5
2020 6
2021 8
2022 6
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
RELAY, Ramucirumab Plus Erlotinib (RAM+ERL) in Untreated Metastatic EGFR-Mutant NSCLC (EGFR+ NSCLC): Association Between TP53 Status and Clinical Outcome.
Nishio M, Paz-Ares L, Reck M, Nakagawa K, Garon EB, Popat S, Ceccarelli M, Graham HT, Visseren-Grul C, Novello S. Nishio M, et al. Among authors: ceccarelli m. Clin Lung Cancer. 2023 Jul;24(5):415-428. doi: 10.1016/j.cllc.2023.02.010. Epub 2023 Mar 21. Clin Lung Cancer. 2023. PMID: 37076395 Free article. Clinical Trial.
Olaratumab-induced Biomarker Modulation in Sarcomas-Response.
Martín-Broto J, Peterson PM, Oakley GJ, Ceccarelli M, Jones RL. Martín-Broto J, et al. Among authors: ceccarelli m. Mol Cancer Ther. 2021 Oct;20(10):2094. doi: 10.1158/1535-7163.MCT-21-0497. Mol Cancer Ther. 2021. PMID: 34607902 No abstract available.
Current Methods to Unravel the Functional Properties of Lysosomal Ion Channels and Transporters.
Festa M, Minicozzi V, Boccaccio A, Lagostena L, Gradogna A, Qi T, Costa A, Larisch N, Hamamoto S, Pedrazzini E, Milenkovic S, Scholz-Starke J, Ceccarelli M, Vitale A, Dietrich P, Uozumi N, Gambale F, Carpaneto A. Festa M, et al. Among authors: ceccarelli m. Cells. 2022 Mar 8;11(6):921. doi: 10.3390/cells11060921. Cells. 2022. PMID: 35326372 Free PMC article. Review.
Porins and small-molecule translocation across the outer membrane of Gram-negative bacteria.
Vergalli J, Bodrenko IV, Masi M, Moynié L, Acosta-Gutiérrez S, Naismith JH, Davin-Regli A, Ceccarelli M, van den Berg B, Winterhalter M, Pagès JM. Vergalli J, et al. Among authors: ceccarelli m. Nat Rev Microbiol. 2020 Mar;18(3):164-176. doi: 10.1038/s41579-019-0294-2. Epub 2019 Dec 2. Nat Rev Microbiol. 2020. PMID: 31792365 Free article. Review.
Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo.
Bachmann M, Rossa A, Varanita T, Fioretti B, Biasutto L, Milenkovic S, Checchetto V, Peruzzo R, Ahmad SA, Patel SH, Lukowski R, Edwards MJ, Ceccarelli M, Gulbins E, Zoratti M, Mattarei A, Szabo I. Bachmann M, et al. Among authors: ceccarelli m. Cell Death Dis. 2022 Dec 20;13(12):1055. doi: 10.1038/s41419-022-05463-8. Cell Death Dis. 2022. PMID: 36539400 Free PMC article.
Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma.
Schöffski P, Bahleda R, Wagner AJ, Burgess MA, Junker N, Chisamore M, Peterson P, Szpurka AM, Ceccarelli M, Tap WD. Schöffski P, et al. Among authors: ceccarelli m. Clin Cancer Res. 2023 Sep 1;29(17):3320-3328. doi: 10.1158/1078-0432.CCR-23-0742. Clin Cancer Res. 2023. PMID: 37382656 Free PMC article. Clinical Trial.
102 results